» Articles » PMID: 27023536

Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors

Abstract

An imbalance between matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) may contribute to liver fibrosis in patients with hepatitis C (HCV) infection. We measured the circulating levels of different MMPs and TIMPs in HCV monoinfected and HIV/HCV coinfected patients and evaluated the potential for anti-HCV therapy to modulate MMP and TIMP levels in HCV subjects. We analyzed 83 plasma samples from 16 HCV monoinfected patients undergoing dual or triple anti-HCV therapy, 15 HIV/HCV coinfected patients with undetectable HIV load, and 10 healthy donors (HD). Levels of MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-10, TIMP-1, and TIMP-2 were measured by a SearchLight Multiplex Immunoassay Kit. MMP-2 and MMP-9 were the highest expressed MMPs among all the analyzed samples and their levels significantly increased in HCV monoinfected and HIV/HCV coinfected subjects compared to HD. TIMP-1 levels were significantly higher in HCV and HIV/HCV subjects compared to HD and were correlated with liver stiffness. These findings raise the possibility of using circulating TIMP-1 as a non-invasive marker of liver fibrosis in HCV infection. A longitudinal study demonstrated that MMP-9 levels significantly decreased (40% reduction from baseline) in patients receiving dual as well as triple direct-acting antivirals (DAA) anti-HCV therapy, which had no effect on MMP-2, TIMP-1, and TIMP-2. As the dysregulation of MMP-2 and MMP-9 may reflect inflammatory processes in the liver, the decrease of MMP-9 following HCV protease inhibitor treatment suggests a positive effect on the reduction of liver inflammation.

Citing Articles

Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression.

Banerjee A, Farci P Int J Mol Sci. 2024; 25(16).

PMID: 39201329 PMC: 11354981. DOI: 10.3390/ijms25168641.


Zinc-Alpha-2-Glycoprotein Peptide Downregulates Type I and III Collagen Expression via Suppression of TGF-β and p-Smad 2/3 Pathway in Keloid Fibroblasts and Rat Incisional Model.

Kim S, Oh J, Roh H, Lee K, Lee J, Lee W Tissue Eng Regen Med. 2024; 21(7):1079-1092.

PMID: 39105875 PMC: 11416446. DOI: 10.1007/s13770-024-00664-y.


Hepatitis C Virus (HCV) Infection: Pathogenesis, Oral Manifestations, and the Role of Direct-Acting Antiviral Therapy: A Narrative Review.

Di Stasio D, Guida A, Romano A, Petruzzi M, Marrone A, Fiori F J Clin Med. 2024; 13(14).

PMID: 39064052 PMC: 11278420. DOI: 10.3390/jcm13144012.


Hepatoprotective Mechanisms Induced by Spinach Methanolic Extract in Rats with Hyperglycemia-An Immunohistochemical Analysis.

Flores-Estrada J, Cano-Martinez A, Vargas-Gonzalez A, Castrejon-Tellez V, Cornejo-Garrido J, Martinez-Rosas M Antioxidants (Basel). 2023; 12(11).

PMID: 38001866 PMC: 10669258. DOI: 10.3390/antiox12112013.


hUMSCs Restore Uterine Function by Inhibiting Endometrial Fibrosis via Regulation of the MMP-9/TIMP-1 Ratio in CDDP-Induced Injury Rats.

Tang Y, Si Y, Liu C, Li C, Qu L, Liu Y Stem Cells Int. 2023; 2023:8014052.

PMID: 36994440 PMC: 10042641. DOI: 10.1155/2023/8014052.


References
1.
Lichtinghagen R, Huegel O, Seifert T, Haberkorn C, Michels D, Flemming P . Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C. Clin Chem. 2000; 46(2):183-92. View

2.
Iredale J, Thompson A, Henderson N . Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation. Biochim Biophys Acta. 2012; 1832(7):876-83. DOI: 10.1016/j.bbadis.2012.11.002. View

3.
Thein H, Yi Q, Dore G, Krahn M . Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS. 2008; 22(15):1979-91. DOI: 10.1097/QAD.0b013e32830e6d51. View

4.
Kim A, Chung R . Coinfection with HIV-1 and HCV--a one-two punch. Gastroenterology. 2009; 137(3):795-814. PMC: 3146750. DOI: 10.1053/j.gastro.2009.06.040. View

5.
Arpino V, Brock M, Gill S . The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol. 2015; 44-46:247-54. DOI: 10.1016/j.matbio.2015.03.005. View